Lee Baylis, MD

GlaxoSmithKline
Durham, NC, United States

Board-certified allergist/immunologist

Disclosure information not submitted.

Presentation(s):

• 1075: Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis and a Vasculitic Phenotype

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time